Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

Similar articles for PubMed (Select 23998566)

1.

[Clinical and experimental characteristics of 20 patients with acute myeloid leukemia with complex variant of t(8; 21)].

Xia J, Chen SN, Pan JL, Wang QR, Wu YF, Wang Y, Zhang J, Shen J, Xue YQ, Ruan CG.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Aug;21(4):815-20. doi: 10.7534/j.issn.1009-2137.2013.04.001. Chinese.

PMID:
23998566
2.

[Analysis of tyrosine kinases gene mutations in core binding factor related acute myeloid leukemia and its clinical significance].

Qiao M, Li WY, Sun AN, Chen SN, Liang JY, Ding ZX, Feng YF, Wu DP.

Zhonghua Xue Ye Xue Za Zhi. 2011 Oct;32(10):679-83. Chinese.

3.

[C-kit, NPM1 and FLT3 gene mutation patterns and their prognostic significance in 656 Chinese patients with acute myeloid leukemia].

Ding ZX, Shen HJ, Miao JC, Chen SN, Qiu QC, Qi XF, Jin ZM, Wu DP, He J.

Zhonghua Xue Ye Xue Za Zhi. 2012 Oct;33(10):829-34. Chinese.

4.

[Heterogeneity of acute myeloid leukemia with the translocation t(8;21)(q22;q22)].

Gritsaev SV, Martynkevich IS, Ziuzgin IS, Kariagina EV, Martynenko LS, Petrova EV, Tsybakova NIu, Ivanova MP, Kostroma II, Tiranova SA, Potikhonova NA, Abdulkadyrov KM.

Ter Arkh. 2014;86(7):45-52. Russian.

PMID:
25314777
5.

Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).

Lai YY, Qiu JY, Jiang B, Lu XJ, Huang XJ, Zhang Y, Liu YR, Shi HL, Lu DP.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Oct;13(5):733-40.

PMID:
16277833
6.

[FMS-like tyrosine kinase 3 gene mutations in acute myeloid leukemia].

Han YL, Zhang SJ, Qiao C, Dai D, Sun XM, Xu YL, Qian SX, Xu W, Wang JS, Li JY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Oct;17(5):1135-9. Chinese.

PMID:
19840437
7.

FLT3 and NPM1 mutations in Chinese patients with acute myeloid leukemia and normal cytogenetics.

Wang L, Xu WL, Meng HT, Qian WB, Mai WY, Tong HY, Mao LP, Tong Y, Qian JJ, Lou YJ, Chen ZM, Wang YG, Jin J.

J Zhejiang Univ Sci B. 2010 Oct;11(10):762-70. doi: 10.1631/jzus.B1000052.

8.

[Analysis of c-kit and JAK2 gene mutations in t(8;21) acute myeloid leukemia].

Li WY, Sun AN, Wu DP.

Zhonghua Xue Ye Xue Za Zhi. 2008 Dec;29(12):797-801. Chinese.

PMID:
19176031
9.

Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG).

Paschka P, Du J, Schlenk RF, Gaidzik VI, Bullinger L, Corbacioglu A, Späth D, Kayser S, Schlegelberger B, Krauter J, Ganser A, Köhne CH, Held G, von Lilienfeld-Toal M, Kirchen H, Rummel M, Götze K, Horst HA, Ringhoffer M, Lübbert M, Wattad M, Salih HR, Kündgen A, Döhner H, Döhner K.

Blood. 2013 Jan 3;121(1):170-7. doi: 10.1182/blood-2012-05-431486. Epub 2012 Oct 31.

10.

Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia.

Marková J, Michková P, Burčková K, Březinová J, Michalová K, Dohnalová A, Maaloufová JS, Soukup P, Vítek A, Cetkovský P, Schwarz J.

Eur J Haematol. 2012 Feb;88(2):128-35. doi: 10.1111/j.1600-0609.2011.01716.x. Epub 2011 Nov 17.

PMID:
21967546
11.

[Analysis of characteristics of 72 cases of t(8;21) acute myeloid leukemia].

Lai YY, Qiu JY, Jiang B, Lu XJ, Huang XJ, Liu YR, Shi Y, Dang H, He Q, Lu DP.

Beijing Da Xue Xue Bao. 2005 Jun 18;37(3):245-8. Chinese.

12.

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.

Schnittger S, Schoch C, Kern W, Mecucci C, Tschulik C, Martelli MF, Haferlach T, Hiddemann W, Falini B.

Blood. 2005 Dec 1;106(12):3733-9. Epub 2005 Aug 2.

13.

Risk assessment in patients with acute myeloid leukemia and a normal karyotype.

Bienz M, Ludwig M, Leibundgut EO, Mueller BU, Ratschiller D, Solenthaler M, Fey MF, Pabst T.

Clin Cancer Res. 2005 Feb 15;11(4):1416-24. Erratum in: Clin Cancer Res. 2005 Aug 1;11(15):5659.

14.

[Clinical analysis of acute myeloid leukemia with t(8;21) (q22;q22) and loss of Y chromosome].

Zhu CY, Yang H, Niu JH, Zhang Q, Xie XL, Wang LJ, Zhu HY, Yao ZL, Yu L, Jing Y.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Aug;22(4):950-6. doi: 10.7534/j.issn.1009-2137.2014.04.013. Chinese.

PMID:
25130809
15.

Cytogenetic analysis of acute myeloid leukemia with t(8;21) from a tertiary care center in India with correlation between clinicopathologic characteristics and molecular analysis.

Parihar M, Kumar JA, Sitaram U, Balasubramanian P, Abraham A, Viswabandya A, George B, Mathews V, Srivastava A, Srivastava VM.

Leuk Lymphoma. 2012 Jan;53(1):103-9. doi: 10.3109/10428194.2011.603447. Epub 2011 Sep 2.

PMID:
21745004
16.

[Clinical and laboratory studies of 11 acute myeloid leukemia patients with t(7;11) (p15;p15) translocation].

Wang SP, Wei SN, Qi JY, Liu XP, Yang HL, Zhao JW, An G, Wang JX.

Zhonghua Xue Ye Xue Za Zhi. 2011 Aug;32(8):533-6. Chinese.

17.

Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16).

Kainz B, Heintel D, Marculescu R, Schwarzinger I, Sperr W, Le T, Weltermann A, Fonatsch C, Haas OA, Mannhalter C, Lechner K, Jaeger U.

Hematol J. 2002;3(6):283-9.

PMID:
12522450
18.

FLT3-internal tandem duplication in a pediatric patient with t(8;21) acute myeloid leukemia.

Kawamura M, Kaku H, Ito T, Funata N, Taki T, Shimada A, Hayashi Y.

Cancer Genet Cytogenet. 2010 Dec;203(2):292-6. doi: 10.1016/j.cancergencyto.2010.07.130.

PMID:
21156247
19.

[An analysis of cytogenetic characteristics and prognosis of 189 t (8; 21) acute myeloid leukemia patients].

Liu XP, Xue YP, Liu SH, Mi YC, Han MZ, Xiao ZJ, Bian SG, Wang JX.

Zhonghua Nei Ke Za Zhi. 2006 Nov;45(11):918-21. Chinese.

PMID:
17313880
20.

Long-term outcomes of de novo acute myeloid leukemia in Thai patients.

Niparuck P, Chuncharunee S, Ungkanont A, Udomtrupayakul U, Aungchaisuksiri P, Rerkamnuatchoke B, Jootar S, Atichartakarn V.

J Med Assoc Thai. 2009 Sep;92(9):1143-9.

PMID:
19772172
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk